Diabetes mellitus is a complex disease that is characterized by the defection of insulin sensitivity in such peripheral tissues as skeletal muscle, adipose tissue and liver. We have previously demonstrated that certain inositol derivatives stimulated glucose uptake accompanied by the translocation of glucose transporter 4 (GLUT4) to the plasma membrane in L6 myotubes. We investigated in this present study whether an oral intake of D-pinitol (PI) and myo-inositol (MI) would affect GLUT4 translocation in the skeletal muscle of mice. PI or MI at 1 g/kg BW administered orally to mice 30 min before a post-oral injection of glucose at 2 g/kg BW resulted in both PI and MI increasing GLUT4 translocation in the skeletal muscle and lowering the plasma glucose and insulin levels. PI and MI, therefore, have the potential to prevent diabetes mellitus by reducing the postprandial blood glucose level and stimulating GLUT4 translocation in the skeletal muscle.
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Key words: D-pinitol; myo-inositol; glucose transporter 4; plasma glucose level; skeletal muscle Diabetes mellitus is associated with cardiovascular diseases, hypertension, hypercholesterolemia, hypertriglyceridemia, hyperglycemia and hyperinsulinemia. [1] [2] [3] One of the optimal methods for managing diabetes mellitus is to control the blood glucose level. It is especially important to reduce the postprandial blood glucose level that is regulated by the action of insulin in suppressing gluconeogenesis in the liver and increasing glucose transport activity in the skeletal muscle and adipose tissue.
Glucose transporter (GLUT) 4, an insulin-sensitive glucose transporter, plays an important role in regulating insulin-stimulated glucose transport into skeletal muscle and adipose tissue. 4) Binding insulin to its receptor leads the translocation of GLUT4 from intracellular storage particles to the cellular surface through a protein phosphorylation cascade involving the phosphatidylinositol-3 kinase/Akt signaling pathway. [5] [6] [7] A defect in glucose transport efficiency, including GLUT4 expression and its activity, causes insulin resistance.
8) It is, thus, important to search for insulin-mimetic compounds in our daily foods which can increase the glucose transport activity by stimulating the translocation of GLUT4.
Inositol stands for 1,2,3,4,5,6-cyclohexanehexol and consists of nine distinct steroisomers, namely, myo-, cis-, allo-, muco-, neo-, epi-, scyllo-, and optical isomers D-chiro-and L-chiro-inositols. D-Pinitol (PI), the 3-Omethyl form of D-chiro-inositol, is also one of the naturally occurring inositol derivatives. Certain inositol derivatives have been reported to be useful in treating diabetes mellitus; for example, D-pinitol from the leaves of Bougainvilla spectabilis has been reported to reduce the blood glucose level in streptozocin (STZ)-induced diabetic rats.
9) The effectiveness of an oral administration of chemically synthesized PI for lowering the plasma glucose level has been evaluated in STZ-induced diabetic rats. 3, 10) Earlier reports have also confirmed that the administration of D-chiro-inositol to diabetic rats, rhesus monkeys, mice and humans increased glucose disposal and improved insulin sensitivity. [11] [12] [13] [14] [15] Among the nine inositol isomers, myo-inositol (MI) is known to be widely distributed in various tissues. 16) It has been reported that MI can be converted to chiro-inositol in such insulin-sensitive tissues as skeletal muscle, adipose tissue and liver. 13, [17] [18] [19] Our previous study demonstrated that inositol derivatives other than MI stimulated the glucose uptake in rat L6 myotubes. 20) The results from an immunoblot analysis revealed that at least D-chiro-, L-chiro-, epi-and muco-inositol, and PI stimulated GLUT4 translocation to the plasma membrane in L6 myotubes and also in the skeletal muscle of rats ex vivo. 20) However, there is no scientific literature available for the efficacy of orally administered inositol derivatives on GLUT4 translocation in skeletal muscle. We selected PI and MI in the present study and evaluated their efficacy for GLUT4 translocation in skeletal muscle after orally administering to C57BL/6 mice.
ECL plusÔ used for western blotting were respectively purchased from Pall Gelman Laboratory (Tokyo, Japan) and GE Healthcare BioScience Corp. (Piscataway, NJ, USA).
Animal treatments. We carried out three animal experiments in this study (the design of each is shown in Fig. 2 ) according to the ''Guidelines for the Care and Use of Experimental Animals'' at Kobe University Rokkodai Campus. Each experiment used male C57BL/6 mice obtained from Japan SLC (Shizuoka, Japan) and acclimatized for 7 d in an air-conditioned room with a controlled environment of 25 AE 1 C under a 12-h light-dark cycle with free access to an AIN-93M purified diet and tap water. Experiment 1. Twenty-four mice (7 weeks old, 22-25 g) were randomly assigned to 6 groups of 4 animals each: water-water (WW), PI-water (PW), MI-water (MW), water-glucose (WG), PI-glucose (PG) and MI-glucose (MG). After fasting for 15 h, PI at 1 g/kg BW was orally administered to the mice of the PW and PG groups, MI at 1 g/kg BW to those of the MW and MG groups, and water at 1 ml/kg BW to those of the WW and WG groups 30 min before starting the oral glucose tolerance test. The dosage of the inositol derivatives was determined from the results of preliminary experiments (data not shown). Glucose at 2 g/kg BW was administered to the mice of the WG, PG and MG groups, and water to those of the WW, PW and MW groups. This administration time is designated as 0 min (Fig. 2) . Blood was collected from the tail vein of each mouse into a heparinized microcentrifuge tube À30, 0, 15, 30, 60, and 120 min after administration and centrifuged at 1;000 Â g for 15 min at 4 C to prepare plasma. The plasma samples were stored at À20 C until needed for analysis.
Experiment 2. Twenty-four male C57BL/6 mice (9 weeks old, 23-26 g) were assigned to 6 groups of 4 animals each in the same way as that for Experiment 1. Treatment with the inositol derivatives and glucose was also carried out in the same way as that for Experiment 1. The mice were sacrificed 30 min after the glucose administration under anesthesia. Plasma was collected by cardiac puncture from each mouse into a heparinized microcentrifuge tube, and plasma samples prepared in the same way as that just described. The soleus muscle was removed from the hind legs of the mice for use in the western blotting analysis. 21) Experiment 3. Sixteen mice (7 weeks old, 22-25 g) were assigned to 4 groups of 4 animals each. After fasting for 15 h, the mice of three groups were orally given PI at 2 g/kg BW and then sacrificed 30, 60, and 120 min after the administration (Fig. 2) . The mice of the remaining group were given water as a vehicle control (1 ml/kg BW) under anesthesia and killed immediately (0-min treatment). Plasma and soleus muscle samples were prepared as already described.
Measurement of the plasma glucose, insulin, cholesterol and triglyceride levels. The plasma glucose, cholesterol and triglyceride levels were measured with the corresponding commercial kits from Wako Pure Chemical Industries (Osaka, Japan). The plasma insulin level was determined with an ELISA kit from Shibayagi Co. (Gunma, Japan) according to the manufacturer's instructions.
Western blot analysis. The plasma membrane fraction and tissue lysate were prepared from skeletal muscle as described previously. 21) Briefly, skeletal muscle was chopped into small pieces with scissors. Aliquots of 100 mg of the chopped pieces were homogenized in buffer A (10 mM Tris-HCl at pH 7.8, 10 mM KCl, 1.5 mM MgCl 2 , 1mM phenylmethylsulfonylfluoride, 0.5 mM dithiothreitol, 5 mg/ml of aprotinin and 10 mg/ml of leupeptin) containing 0.1% Nonidet P-40 and passed through a 22-gauge needle three times. The homogenate was spun at 1;000 Â g for 10 min at 4 C. The resulting pellet was resuspended in buffer A and spun at 1;000 Â g for another 10 min at 4 C. The plasma membrane fraction was obtained by resuspending the resulting pellet in buffer A containing 1% Nonidet P-40, and centrifuging at 10;000 Â g for 20 min at 4 C. To obtain the tissue lysate, skeletal muscle was homogenized in buffer A and lysed with buffer B (10 mM Tris at pH 8.0, 150 mM NaCl, 1.0% [v/v] Nonident P-40, 0.5% [w/v] sodium deoxycholate, 0.1% [w/v] sodium dodecyl sulfate (SDS), 0.5 mM DTT, 1 mM phenylmethylsulfonylfluoride, 0.5 mM dithiothreitol, 5 mg/ml of aprotinin and 10 mg/ml of leupeptin). The lysate was obtained by centrifuging at 16;000 Â g for 20 min at 4 C. Aliquots of 3 mg and 10 mg of proteins of the plasma membrane fraction were respectively used for detecting GLUT4 translocation and IR, while 3 mg of proteins of the tissue lysate were used for detecting GLUT4 expression. After the proteins had been separated by 8% sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), they were transferred to a PDVF membrane and blocked for 1 h with 1% (w/v) non-fat dry milk in TBST (10 mM Tris-HCl at pH 8.0, 150 mM NaCl and 0.05% Tween-20). The membrane was then incubated for 1 h at room temperature with the primary antibody for GLUT4 (anti-GLUT4, 1:1500) and IR as the internal control of the plasma membrane fraction (anti-IR, 1:750). The membrane was further incubated for 1 h at room temperature with an appropriate secondary antibody conjugated with horseradish peroxidase. Specific immuno-complexes were detected with the ECL plusÔ reagent according to the manufacturer's instructions. Statistical analysis. Data were subjected to a one-way analysis of variance (ANOVA) followed by the Tukey multiple-comparison test. Each data value is expressed as the mean AE standard error, significance being defined as p < 0:05.
Results
The results from the oral glucose tolerance test in Experiment 1 show that the plasma glucose level of the WG group significantly increased after 15 min, reached a maximum after 30 min and then decreased in comparison with that of the WW group (Fig. 3A) . Under the same conditions, the plasma glucose level of the PG and MG groups was significantly lower than that of the WG group after 30 min and 60 min. Moreover, maximum level for these two groups was reached 15 min after the glucose injection and was reached faster than that of the WG group. There was no significant difference among the WW, PW and MW groups at any time. The calculated area under the curve (AUC) for the PG group was significantly lower than that for the WG group (Fig. 3B) .
Experiment 2 was almost the same as Experiment 1 to examine the translocation of GLUT4 in the skeletal muscle of the mice given PI and MI. The results confirm that the plasma glucose level of the WG group was significantly higher than that of the other groups (Fig. 4A) . PI and MI respectively administered to mice of the PG and MG groups resulted in the plasma glucose level being significantly lower than that of the WG group. In contrast, the plasma glucose level of the PW and MW groups was almost the same as that of the WW group. It was noted that PI and MI also tended to decrease the plasma insulin level in the glucose-loaded mice without statistical significance (Fig. 4B ). The homeostasis model assessment of insulin resistance (HOMA-IR) was calculated as a clinical parameter for the insulin resistance. The HOMA-IR value for the WG group was markedly higher than that for the WW group (Fig. 4C) , while the HOMA-IR values for the PG and MG groups were lower than that for the WG group; in particular, the value for the MG group was significantly lower than that for the WG group. We confirmed in the same experiment that the levels of plasma cholesterol and triglyceride were not affected by the inositol derivatives (data not shown). These results show that PI and MI have the potential to affect glucose metabolism under hyperglycemic conditions, while they did not affect lipid metabolism. As shown in Fig. 5A and B, the oral administration of PI, MI and glucose tended to increase GLUT4 translocation to the plasma membrane when compared with the WW group as the control. The expression levels of IR in the plasma membrane fraction and of GLUT4 expression in the tissue lysate remained unchanged under the same experimental conditions (Fig. 5A) . The increased density of GLUT4 in the plasma membrane fraction of each group calculated from Fig. 5B gives values for the PW, MW, WG, PG and MG groups of 1.1 (2.1-1.0), 1.0 (2.0-1.0), 1.1 (2.1-1.0), 3.0 (4.0-1.0) and 3.7 (4.7-1.0), respectively. These results demonstrate an additive or synergistic effect between the inositol derivatives and glucose, because the increased density of GLUT4 translocation for the PG (3.0) and MG (3.7) groups was higher than the sum of the increased density of the PW and WG groups (2.2) or of the MW and PW groups (2.1).
We found in Experiment 2 that orally administered PI and MI stimulated significant GLUT4 translocation to the plasma membrane of skeletal muscle under the glucose-loaded conditions. Since a similar effect was apparent even without glucose loading, a time-course experiment was carried out by using a higher dosage of PI (2 g/kg BW) to confirm the PI-induced GLUT4 translocation without glucose loading (Experiment 3). As shown in Fig. 6A and B, PI slightly increased the amount of GLUT4 in the plasma membrane fractions after 30 min without the significance. However, PI significantly induced GLUT4 translocation in comparison with the 0-min level 60 min and 120 min after its administration ( Fig. 6A and B) . We confirmed that there was no change in the expression level of IR at any time (Fig. 6A) . Moreover, PI had no effect on the plasma glucose level by 120 min (Fig. 6C) . A, GLUT4 and IR in the plasma membrane fraction and GLUT4 in the tissue lysate from skeletal muscle of mice. The protein levels of GLUT4 and IR were detected by immunoblotting as described in the Materials and Methods section. B, GLUT4 translocation was estimated by measuring the density of the GLUT4 band in the plasma membrane fraction from each mouse. Data are presented as the mean AE SD (n ¼ 4). Different superscripted letters indicate a significant difference from the control; p < 0:05 using a one-way analysis of variance (ANOVA) followed by the Tukey multiplecomparison test. A, GLUT4 and IR in the plasma membrane fraction from skeletal muscle of mice. Proteins were subjected to SDS-polyacrylamide gel electrophoresis, transferred to a PVDF membrane, and then GLUT4 and IR were detected by immunoblotting as described in the Materials and Methods section. B, GLUT4 translocation was estimated by measuring the density of the GLUT4 band in the plasma membrane fraction from each mouse. C, Time-course effects of the plasma glucose level in the PI-dosed mice. Data are presented as the mean AE SD (n ¼ 4). Different superscripted letters indicate a significant difference from the control; p < 0:05 using a one-way analysis of variance (ANOVA) followed by the Tukey multiplecomparison test.
Discussion
The results of this study demonstrate that orally administered PI and MI had the ability to stimulate translocation of GLUT4 to the plasma membrane of skeletal muscle in mice (Figs. 5 and 6 ). This is the first report of an oral intake of inositol derivatives stimulating GLUT4 translocation in skeletal muscle, although our previous report 20) demonstrated that certain inositol derivatives including PI, stimulated GLUT4 translocation in L6 myotubes and in the skeletal muscle of rats ex vivo. Stimulation of GLUT4 translocation in skeletal muscle led to a decrease in the plasma glucose level under glucose-loaded hyperglycemic conditions (Figs. 3  and 4 ). Other reports have also shown that certain inositol derivatives revealed insulin-mimic effects in a diabetic animal model; e.g., a decreased plasma glucose level was observed from the result of OGTT in synthesized D-chiro-inositol-administered STZ rats 14) and in D-chiro-inositol-rich buckwheat extract-fed KK-A y mice. 15) The findings in this study, therefore, provide a novel approach to the underlying mechanism for the insulin-mimic effects of inositol derivatives.
Our results show that both PI and MI decreased the plasma glucose level after glucose loading (Figs. 3 and  4) , accompanied by significant GLUT4 translocation (Fig. 5) . Some of the current results are in agreement with our previous ones that PI had the ability to stimulate glucose uptake and GLUT4 translocation in L6 myotubes and in rat skeletal muscle ex vivo, while MI stimulated neither GLUT4 translocation nor glucose uptake activity. 20) This inconsistency is probably due to the metabolic conversion of MI to other inositol derivatives in the body. [17] [18] [19] Under our experiment conditions, MI, at least in part, would be converted to D-chiro-inositol and lead to the stimulation of GLUT4 translocation in skeletal muscle and to a decrease in the plasma glucose level. Pak et al. 17) have shown that the conversion of labeled [
3 H]-MI to [ 3 H]-chiro-inositol was 7.6% and 8.8% in rat blood and muscle, respectively. Kennington et al. 22) have demonstrated that the levels of MI and chiro-inositol in the muscle and liver were correlated with their levels in urine and serum. It has been reported that type 2 diabetic patients 23) and mice 24) had higher urinary excretion of MI and chiroinositol (the sum of the D and L isomers) than normal subjects, whereas a linear relationship has also been reported between their decrease in urinary excretion and the degree of insulin resistance. 13, 22, 25) On the other hand, a negative effect of myo-inositol has been reported on lowering the plasma glucose level in normal and STZ-dosed rats. [26] [27] [28] Clarification of the bioavailability of inositol derivatives, therefore, remains an important issue in the future.
Although PI and MI stimulated GLUT4 translocation in skeletal muscle (Figs. 5 and 6 ), a decrease in the plasma glucose level was apparent in the glucose-loaded animals, but not in the control mice (Figs. 3, 4 and 6) . Previous studies have also demonstrated that inositol derivatives lowered the plasma glucose level under such hyperglycemic conditions as those present in diabetes model animals. 9, 11, 14, 15, 24, 29) It has been reported for normal animals, however, that D-chiro-inositol failed to decrease the plasma glucose level in mice and rats. 9, 11) These results suggest that there is underlying unknown regulating mechanism causing acute hypoglycemia in normal animals after the intake of such inositol derivatives as PI and MI.
We observed in the present study the interesting phenomenon that inositol derivatives and insulin showed an additive or synergistic effect on GLUT4 translocation (Fig. 5) . Moreover, PI and MI tended to save insulin secretion under the glucose-loaded hyperglycemic condition, resulting in a significant decrease in the HOMA-IR value (Fig. 4) . Although we did not address the underlying mechanism for the action of PI and MI on GLUT4 translocation, these results present a clue. It is suggested that the mechanism of action of these inositol derivatives is different from that of insulin. We presume that these compounds activated phosphoinositide 3-kinase and/or 5 0 AMP-activated protein kinase to stimulate GLUT4 translocation. We are progressing with further experiments using L6 myotubes in vitro to clarify the detailed mechanism of action of inositol derivatives. In conclusion, PI and MI (probably acting after conversion to D-chiro-inositol) were effective compounds for lowering the postprandial plasma glucose and insulin levels by stimulating GLUT4 translocation in skeletal muscle. These compounds are therefore potentially useful for preventing diabetes mellitus.
